Neuroleptic malignant syndrome (NMS) is a potentially life-threatening condition that has been associated with antipsychotic use. Most diagnostic criteria include fever and muscle rigidity, although NMS may present without either. Diagnostic uncertainty in such cases may result in delays in diagnosis and management, leading to adverse consequences for these patients. The differential diagnosis of NMS is broad and includes a number of neurological, medical and psychiatric conditions as well as substance and medication-induced disorders. A case is described that illustrates an atypical presentation of NMS and demonstrates some of the challenges in its diagnosis. Limitations of current NMS criteria are also examined, and suggestions for future criteria are presented. © 1998-2005 Canadian Association of Emergency Physicians.
CITATION STYLE
Seitz, D. P. (2005). Diagnostic uncertainty in a case of neuroleptic malignant syndrome. Canadian Journal of Emergency Medicine, 7(4), 266–272. https://doi.org/10.1017/S1481803500014421
Mendeley helps you to discover research relevant for your work.